172 related articles for article (PubMed ID: 18729092)
1. Effects of vanadium-containing compounds on membrane lipids and on microdomains used in receptor-mediated signaling.
Roess DA; Smith SML; Winter P; Zhou J; Dou P; Baruah B; Trujillo AM; Levinger NE; Yang X; Barisas BG; Crans DC
Chem Biodivers; 2008 Aug; 5(8):1558-1570. PubMed ID: 18729092
[TBL] [Abstract][Full Text] [Related]
2. The anti-diabetic bis(maltolato)oxovanadium(IV) decreases lipid order while increasing insulin receptor localization in membrane microdomains.
Winter PW; Al-Qatati A; Wolf-Ringwall AL; Schoeberl S; Chatterjee PB; Barisas BG; Roess DA; Crans DC
Dalton Trans; 2012 Jun; 41(21):6419-30. PubMed ID: 22569684
[TBL] [Abstract][Full Text] [Related]
3. Effects of vanadium(IV) compounds on plasma membrane lipids lead to G protein-coupled receptor signal transduction.
Althumairy D; Murakami HA; Zhang D; Barisas BG; Roess DA; Crans DC
J Inorg Biochem; 2020 Feb; 203():110873. PubMed ID: 31706224
[TBL] [Abstract][Full Text] [Related]
4. Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends.
Ścibior A; Pietrzyk Ł; Plewa Z; Skiba A
J Trace Elem Med Biol; 2020 Sep; 61():126508. PubMed ID: 32305626
[TBL] [Abstract][Full Text] [Related]
5. Sarcoplasmic reticulum calcium ATPase is inhibited by organic vanadium coordination compounds: pyridine-2,6-dicarboxylatodioxovanadium(V), BMOV, and an amavadine analogue.
Aureliano M; Henao F; Tiago T; Duarte RO; Moura JJ; Baruah B; Crans DC
Inorg Chem; 2008 Jul; 47(13):5677-84. PubMed ID: 18510311
[TBL] [Abstract][Full Text] [Related]
6. Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes.
Pereira MJ; Carvalho E; Eriksson JW; Crans DC; Aureliano M
J Inorg Biochem; 2009 Dec; 103(12):1687-92. PubMed ID: 19850351
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
[TBL] [Abstract][Full Text] [Related]
8. Action mechanism of bis(allixinato)oxovanadium(IV) as a novel potent insulin-mimetic complex: regulation of GLUT4 translocation and FoxO1 transcription factor.
Hiromura M; Nakayama A; Adachi Y; Doi M; Sakurai H
J Biol Inorg Chem; 2007 Nov; 12(8):1275-87. PubMed ID: 17805585
[TBL] [Abstract][Full Text] [Related]
9. Correlation of insulin-enhancing properties of vanadium-dipicolinate complexes in model membrane systems: phospholipid langmuir monolayers and AOT reverse micelles.
Sostarecz AG; Gaidamauskas E; Distin S; Bonetti SJ; Levinger NE; Crans DC
Chemistry; 2014 Apr; 20(17):5149-59. PubMed ID: 24615733
[TBL] [Abstract][Full Text] [Related]
10. Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats.
Buglyó P; Crans DC; Nagy EM; Lindo RL; Yang L; Smee JJ; Jin W; Chi LH; Godzala Iii ME; Willsky GR
Inorg Chem; 2005 Jul; 44(15):5416-27. PubMed ID: 16022540
[TBL] [Abstract][Full Text] [Related]
11. Insulin-enhancing vanadium(III) complexes.
Melchior M; Rettig SJ; Liboiron BD; Thompson KH; Yuen VG; McNeill JH; Orvig C
Inorg Chem; 2001 Aug; 40(18):4686-90. PubMed ID: 11511216
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of insulin signaling pathway in adipocytes by oxovanadium(IV) complexes.
Basuki W; Hiromura M; Adachi Y; Tayama K; Hattori M; Sakurai H
Biochem Biophys Res Commun; 2006 Oct; 349(3):1163-70. PubMed ID: 16970914
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol-enriched membrane microdomains are needed for insulin signaling and proliferation in hepatic cells.
Fonseca MC; França A; Florentino RM; Fonseca RC; Lima Filho ACM; Vidigal PTV; Oliveira AG; Dubuquoy L; Nathanson MH; Leite MF
Am J Physiol Gastrointest Liver Physiol; 2018 Jul; 315(1):G80-G94. PubMed ID: 29471671
[TBL] [Abstract][Full Text] [Related]
14. Chemistry and insulin-mimetic properties of bis(acetylacetonate)oxovanadium(IV) and derivatives.
Amin SS; Cryer K; Zhang B; Dutta SK; Eaton SS; Anderson OP; Miller SM; Reul BA; Brichard SM; Crans DC
Inorg Chem; 2000 Feb; 39(3):406-16. PubMed ID: 11229556
[TBL] [Abstract][Full Text] [Related]
15. Bis(acetylacetonato)-oxovanadium(iv), bis(maltolato)-oxovanadium(iv) and sodium metavanadate induce antilipolytic effects by regulating hormone-sensitive lipase and perilipin via activation of Akt.
Liu JC; Yu Y; Wang G; Wang K; Yang XG
Metallomics; 2013 Jun; 5(7):813-20. PubMed ID: 23576171
[TBL] [Abstract][Full Text] [Related]
16. Insulin receptors and downstream substrates associate with membrane microdomains after treatment with insulin or chromium(III) picolinate.
Al-Qatati A; Winter PW; Wolf-Ringwall AL; Chatterjee PB; Van Orden AK; Crans DC; Roess DA; Barisas BG
Cell Biochem Biophys; 2012 Apr; 62(3):441-50. PubMed ID: 22101510
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of insulin sensitization by BMOV (bis maltolato oxo vanadium); unliganded vanadium (VO4) as the active component.
Peters KG; Davis MG; Howard BW; Pokross M; Rastogi V; Diven C; Greis KD; Eby-Wilkens E; Maier M; Evdokimov A; Soper S; Genbauffe F
J Inorg Biochem; 2003 Aug; 96(2-3):321-30. PubMed ID: 12888267
[TBL] [Abstract][Full Text] [Related]
18. Effect of vanadium on insulin sensitivity and appetite.
Wang J; Yuen VG; McNeill JH
Metabolism; 2001 Jun; 50(6):667-73. PubMed ID: 11398143
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
Yuen VG; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
[TBL] [Abstract][Full Text] [Related]
20. Lipid rafts, KCa/ClCa/Ca2+ channel complexes and EGFR signaling: Novel targets to reduce tumor development by lipids?
Guéguinou M; Gambade A; Félix R; Chantôme A; Fourbon Y; Bougnoux P; Weber G; Potier-Cartereau M; Vandier C
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2603-20. PubMed ID: 25450343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
